Suppr超能文献

静脉血样比反复皮肤针刺试验更适合献血者血红蛋白二线筛查。

Venous sample is superior to repeated skin-prick testing in blood donor haemoglobin second-line screening.

机构信息

Finnish Red Cross Blood Service, Helsinki, Finland.

出版信息

Vox Sang. 2020 Nov;115(8):617-623. doi: 10.1111/vox.12920. Epub 2020 Apr 20.

Abstract

BACKGROUND

Blood donor haemoglobin concentration (Hb) is commonly measured from a skin-prick sample. However, the skin-prick sample is prone to preanalytical error and variation, which may lead to false deferrals due to low Hb.

STUDY DESIGN AND METHODS

We assessed the efficacy of two second-line screening models for the evaluation of blood donors failing the initial skin-prick test. In the venous model (n = 305), Hb was measured from a venous sample at the donation site. In the skin-prick model (n = 331), two additional skin-prick samples were measured. All on-site Hb measurements were performed with HemoCue Hb201+ (HemoCue AB) point-of-care (POC) device. Hb in the venous samples was later also determined with a hematology analyzer (Sysmex XN, Sysmex Co.) to obtain the donor's correct Hb. A questionnaire evaluated Blood Service nurses' preferences regarding Hb assessment.

RESULTS

Significantly less donors were deferred from donation with venous model (40%) than with skin-prick model (51%; chi-square test P = 0·004). Only two donors (0·7%) were incorrectly accepted in the venous model. Further, Blood Service nurses preferred venous model over skin-prick model. After the study, the venous model was implemented nationwide, and in the first two months after implementation, the deferral rate due to low Hb decreased from 2·7% to 1·9%.

CONCLUSION

A venous sample for blood donor Hb second-line screening significantly decreased low Hb deferrals compared to repeated skin-prick testing without compromising donor safety. Valuable donations can be recovered by implementing a practical second-line screening model based on venous sampling.

摘要

背景

通常通过皮肤刺破样本测量献血者的血红蛋白浓度(Hb)。然而,皮肤刺破样本容易受到分析前误差和变异的影响,这可能导致由于 Hb 低而导致错误的延期。

研究设计和方法

我们评估了两种二线筛选模型在评估初始皮肤刺破试验失败的献血者中的效果。在静脉模型(n=305)中,在献血现场从静脉样本中测量 Hb。在皮肤刺破模型(n=331)中,测量了两个额外的皮肤刺破样本。所有现场 Hb 测量均使用 HemoCue Hb201+(HemoCue AB)即时护理(POC)设备进行。后来,还使用血液分析仪(Sysmex XN,Sysmex Co.)测量静脉样本中的 Hb,以获得献血者的正确 Hb。问卷调查评估了血液服务护士对 Hb 评估的偏好。

结果

与皮肤刺破模型(51%;卡方检验 P=0.004)相比,静脉模型显著减少了因 Hb 低而被延期献血的人数(40%)。只有两名献血者(0.7%)在静脉模型中被错误接受。此外,血液服务护士更喜欢静脉模型而不是皮肤刺破模型。研究结束后,静脉模型在全国范围内实施,实施后的头两个月,由于 Hb 低导致的延期率从 2.7%降至 1.9%。

结论

与反复皮肤刺破测试相比,用于献血者 Hb 二线筛查的静脉样本可显著降低 Hb 低导致的延期,同时不影响献血者的安全性。通过实施基于静脉取样的实用二线筛选模型,可以回收有价值的献血。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验